Afreen Shariff

779 total citations
24 papers, 489 citations indexed

About

Afreen Shariff is a scholar working on Oncology, Health and Epidemiology. According to data from OpenAlex, Afreen Shariff has authored 24 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 5 papers in Health and 5 papers in Epidemiology. Recurrent topics in Afreen Shariff's work include Cancer Immunotherapy and Biomarkers (10 papers), Social Media in Health Education (5 papers) and Health Literacy and Information Accessibility (4 papers). Afreen Shariff is often cited by papers focused on Cancer Immunotherapy and Biomarkers (10 papers), Social Media in Health Education (5 papers) and Health Literacy and Information Accessibility (4 papers). Afreen Shariff collaborates with scholars based in United States, Australia and Philippines. Afreen Shariff's co-authors include Tejas Desai, Deeba Minhas, Xiangming Fang, Aabid Shariff, María Ferris, Cynthia Christiano, David A. D’Alessio, William S. Yancy, Leonor Corsino and Joan T. Merrill and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Afreen Shariff

24 papers receiving 477 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Afreen Shariff United States 8 245 235 64 46 41 24 489
Rahim Hirani United States 9 108 0.4× 119 0.5× 44 0.7× 19 0.4× 15 0.4× 40 399
Yash Pershad United States 9 97 0.4× 135 0.6× 75 1.2× 24 0.5× 37 0.9× 25 479
Neilanjan Nandi United States 8 53 0.2× 74 0.3× 40 0.6× 19 0.4× 12 0.3× 23 301
Hiroto Narimatsu Japan 10 133 0.5× 153 0.7× 90 1.4× 36 0.8× 31 0.8× 44 391
Tasnima Abedin Canada 9 101 0.4× 65 0.3× 40 0.6× 13 0.3× 14 0.3× 25 333
Mike D Cadogan Australia 7 212 0.9× 337 1.4× 34 0.5× 72 1.6× 89 2.2× 15 601
Michael S. Cowher United States 8 187 0.8× 205 0.9× 90 1.4× 31 0.7× 38 0.9× 16 524
Mohammed Al-Hamadani United States 8 152 0.6× 161 0.7× 85 1.3× 22 0.5× 28 0.7× 9 485
Grant Cumming United Kingdom 14 140 0.6× 97 0.4× 47 0.7× 29 0.6× 24 0.6× 43 594
Brian Stork United States 9 265 1.1× 248 1.1× 26 0.4× 44 1.0× 28 0.7× 22 445

Countries citing papers authored by Afreen Shariff

Since Specialization
Citations

This map shows the geographic impact of Afreen Shariff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Afreen Shariff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Afreen Shariff more than expected).

Fields of papers citing papers by Afreen Shariff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Afreen Shariff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Afreen Shariff. The network helps show where Afreen Shariff may publish in the future.

Co-authorship network of co-authors of Afreen Shariff

This figure shows the co-authorship network connecting the top 25 collaborators of Afreen Shariff. A scholar is included among the top collaborators of Afreen Shariff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Afreen Shariff. Afreen Shariff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
David, Matthias, et al.. (2025). Acquired Generalized Lipodystrophy as an Adverse Event of Combined Immune Checkpoint Inhibitor Therapy. JCEM Case Reports. 3(3). luaf023–luaf023. 2 indexed citations
2.
Kotwal, Anupam, et al.. (2024). Endocrinopathies Associated With Immune Checkpoint Inhibitor Use. Endocrine Practice. 30(6). 584–591. 5 indexed citations
3.
Phinney, Donna, et al.. (2024). e-Consults for Immune-Related Toxicities Improve Patient Access and Reduce Costs. Oncology Issues. 39(1). 30–35. 1 indexed citations
4.
Hallemeier, Christopher L., et al.. (2023). Radiation of bilateral adrenal metastases is associated with a high risk of primary adrenal insufficiency. Clinical Endocrinology. 99(1). 35–42. 2 indexed citations
5.
Cheung, Yee-Ming Melody, Ole‐Petter R. Hamnvik, Afreen Shariff, & Emily J. Gallagher. (2023). Dearth of ICD Codes for Complications of Immune Checkpoint Inhibitors Impedes Clinical Care and Research. Journal of the Endocrine Society. 7(4). bvad019–bvad019. 2 indexed citations
6.
Yeung, Howa, Ragini R. Kudchadkar, David H. Lawson, et al.. (2023). Cutaneous and Noncutaneous Adverse Effects in Patients with Advanced Melanoma Receiving Immunotherapy. SHILAP Revista de lepidopterología. 3(6). 100232–100232. 1 indexed citations
7.
Ferreira, Michelle, Meghana Rao, Arif H. Kamal, & Afreen Shariff. (2022). Top Ten Tips Palliative Care Clinicians Should Know About Managing Immune-Mediated Endocrine Toxicities in Cancer. Journal of Palliative Medicine. 25(11). 1715–1720. 1 indexed citations
8.
Clarke, Jeffrey, Xiaofei F. Wang, Thomas E. Stinchcombe, et al.. (2022). A Phase 2 Clinical Trial of Combination Nivolumab, Ipilimumab, and Paclitaxel in Patients With Untreated Metastatic NSCLC: The OPTIMAL Trial. JTO Clinical and Research Reports. 3(6). 100337–100337. 1 indexed citations
9.
Lee, Terry, Mingzhe Hu, Durga S. Borkar, et al.. (2022). Evaluation of a deep learning supported remote diagnosis model for identification of diabetic retinopathy using wide-field Optomap. Annals of Eye Science. 7. 11–11. 3 indexed citations
10.
Shariff, Afreen, et al.. (2021). The management of toxicities from immune, targeted and ADCs treatments in patients with urothelial cancer. Urologic Oncology Seminars and Original Investigations. 41(10). 410–419. 7 indexed citations
11.
Shareef, Javedh, et al.. (2020). A Systematic Review on the Impact of Clinical Pharmacist Interventions in Patients with Mental Health Disorders. Clinical Schizophrenia & Related Psychoses. 14(3). 74–85. 1 indexed citations
12.
Shariff, Afreen, et al.. (2020). Type 2 Diabetes and Atherosclerotic Cardiovascular Disease in South Asians: a Unique Population with a Growing Challenge. Current Diabetes Reports. 20(1). 4–4. 10 indexed citations
13.
Anders, Carey K., Nicole R. LeBoeuf, Lara Bashoura, et al.. (2020). What’s the Price? Toxicities of Targeted Therapies in Breast Cancer Care. American Society of Clinical Oncology Educational Book. 40(40). 55–70. 15 indexed citations
14.
Shariff, Afreen, et al.. (2020). SAT-414 A Single Center Retrospective Analysis and Review of Endocrinopathies from Immune Checkpoint Inhibitors Between 2007 and 2017. Journal of the Endocrine Society. 4(Supplement_1). 1 indexed citations
15.
Shariff, Afreen, et al.. (2017). Cardiovascular Outcome Trial Update in Diabetes: New Evidence, Remaining Questions. Current Diabetes Reports. 17(9). 67–67. 1 indexed citations
16.
Shariff, Afreen & David A. D’Alessio. (2017). Primary Adrenal Insufficiency from Immune Checkpoint Inhibitors. AACE Clinical Case Reports. 4(3). 232–234. 5 indexed citations
17.
Desai, Tejas, Afreen Shariff, Aabid Shariff, et al.. (2016). Quantifying the Twitter Influence of Third Party Commercial Entities versus Healthcare Providers in Thirteen Medical Conferences from 2011 – 2013. PLoS ONE. 11(9). e0162376–e0162376. 13 indexed citations
18.
Desai, Tejas, et al.. (2013). Is Content Really King? An Objective Analysis of the Public's Response to Medical Videos on YouTube. PLoS ONE. 8(12). e82469–e82469. 271 indexed citations
19.
Shariff, Afreen, Xiangming Fang, & Tejas Desai. (2013). Using Social Media to Create a Professional Network Between Physician-Trainees and the American Society of Nephrology. Advances in Chronic Kidney Disease. 20(4). 357–363. 4 indexed citations
20.
Desai, Tejas, Afreen Shariff, Aabid Shariff, et al.. (2012). Tweeting the Meeting: An In-Depth Analysis of Twitter Activity at Kidney Week 2011. PLoS ONE. 7(7). e40253–e40253. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rahim Hirani Breakdown of academic impact, for papers by Yash Pershad Breakdown of academic impact, for papers by Neilanjan Nandi Breakdown of academic impact, for papers by Hiroto Narimatsu Breakdown of academic impact, for papers by Tasnima Abedin Breakdown of academic impact, for papers by Mike D Cadogan Breakdown of academic impact, for papers by Michael S. Cowher Breakdown of academic impact, for papers by Mohammed Al-Hamadani Breakdown of academic impact, for papers by Grant Cumming Breakdown of academic impact, for papers by Brian Stork
Rankless by CCL
2026